KR vs RGEN · P/E 19, rev $147.64B vs P/E 143, rev $204.1M
Kroger Company (KR) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported KR revenue for 2026-01-31 was $147.64B. Net income was $1.02B. Revenue was up 0.4% from 2025-02-01 to 2026-01-31. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
KR currently screens at market cap $46.17B and trailing P/E 19.0. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the KR and RGEN stock pages for the full models.
Not investment advice.